A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis.
J Indian Med Assoc
;
2007 May; 105(5): 260-2
Article
Dans Anglais
| IMSEAR
| ID: sea-103064
ABSTRACT
Diclofenac sodium, a non-selective cyclo-oxygenase inhibitor and etoricoxib, a selective cyclo-oxygenase-2 inhibitor have been widely used in treatment of patients with osteo-arthritis. Five hundred and eighty-five patients with uncomplicated knee osteo-arthritis were randomly allocated into 3 equal groups and received either diclofenac sodium, etoricoxib or placebo in a double-blind manner. The response in both the drug groups was comparable and much more than placebo group. The study shows that etoricoxib provides better clinical efficacy and gastro-intestinal tolerability in osteo-arthritis in comparison to diclofenac sodium presumably due to the selective inhibition of cyclo-oxygenase-2 by etoricoxib.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Pyridines
/
Sulfones
/
Femelle
/
Humains
/
Mâle
/
Diclofenac
/
Méthode en double aveugle
/
Résultat thérapeutique
/
Inhibiteurs des cyclooxygénases
/
Adulte
Type d'étude:
Essai clinique contrôlé
langue:
Anglais
Texte intégral:
J Indian Med Assoc
Année:
2007
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS